November 21, 2026

GSK rejoinder and our response

News Desk

bdnews24.com

Published : 06 Apr 2014, 03:02 PM

Updated : 23 Apr 2022, 02:32 PM

GlaxoSmithKline (GSK), manufacturer of Junior Horlicks, has sent a rejoinder to bdnews24.com regarding the story - Junior Horlicks without DHA!.

Following are the text of the rejoinder and our response:

“Dear Sirs,

Sub: Rejoinder to news captioned “Junior Horlicks without DHA” dated 03.04.2014

We, GlaxoSmithKline Bangladesh Limited, a company registered in Bangladesh and having its corporate office at House No.2A, Road No. 138, Gulshan-1, Dhaka - 1212 (‘GSK’ in short), would like to draw your attention to the headlined story captioned "Junior Horlicks without DHA" in your online publication, bdnews24.com (the “Report”) dated 03.04.2014. In the story, one of your colleagues, named Mr. Faijul Siddikii (the “Reporter”), has tried to find faults with the nutrient contents of New Junior Horlicks with DHA (the “Product”) manufactured and marketed by GSK.

It is unfortunate that the Reporter has without verifying the facts came to certain conclusions which attempt to show GSK in a poor light, when the facts are otherwise. The Report under reference, as presented in your website, is an attempt to distort facts, is baseless and motivated. In this regard, we would like to present the following rejoinder to the said Report:

1. GSK is extremely disappointed with the malicious technique used by the concerned Reporter, who, in complete violation of the media ethics, misquoted the conversation between him and our representative, Mr. Lokman Hossain. When contacted by the Reporter, he was clearly informed by Mr. Hossain that purported laboratory test carried out by Mr. Rezaul Karim of Bangladesh Council of Scientific and Industrial Research (BCSIR) mentioned the product as ‘HORLICKS” and not “NEW JUNIOR HORLICKS WITH DHA”, which is a separate and distinct product of GSK.

It is pertinent to take note that HORLICKS has a range of products available for various age groups under different brand names (like HORLICKS, JUNIOR HORLICKS, LITE HORLICKS, WOMEN’S HORLICKS, MOTHER’s HORLICKS) and product formulations of each of these products are different and they have different nutrient contents. As such and until we know which specific Horlicks product was tested, it cannot be established with certainty that the Horlicks tested by Mr. Karim is actually the JUNIOR HORLICKS product with DHA.

2. Apart from the basic distinction which the Reporter had failed to make, our representative Mr. Hossain specifically requested the Reporter in writing to provide details of the product which has been tested by Mr. Karim including product name, batch number, manufacturing date, expiry date, name of manufacturer and distributor (if any), laboratory name (as it was not mentioned anywhere in the report) which the Reporter blatantly failed to provide. He instead, chose to proceed with publication of an incorrect and misconceived Report. Evidently, in publishing the Report, both bdnews24.com, the Editor and the Reporter acted in haste and failed to verify the contents of the Report at the cost of ignoring basic standards of journalism. This conduct, leading to the publication of the Report, clearly demonstrates your inclination toward sensationalism rather than the truth.

3. There are several other mis-statements and factually incorrect statements in your Report. The Report intentionally misquoted the statement of Mr. Hossain mentioning that the GSK products are tested in its “own laboratories” when, in fact, he had only quoted that it was tested and validated. GSK is dismayed to note that the Reporter resorted to distortion of the truth in alleging that the tests were carried out by GSK at its own laboratory only.

4. The Report is also inaccurate and wrong in stating that the Product contains 0.55g of DHA Oil in every 40 g which we assume, has been made, without even looking at our Product. It is a malafide statement on part of both the Reporter as well as the analyst to state that the “New Junior Horlicks with DHA” does not contain any DHA. The fact, as is clearly mentioned in the Nutrition Panel of the Product packaging, shows that ‘every 100gm of the Product contains 20mg of DHA’, which is also supported by the laboratory report obtained by GSK from an international reputed independent testing body entrusted to test the products of similar kind.

However, the Reporter failed to verify the authenticity of the test report by Mr. Karim and published the Report without getting any confirmation from the concerned representatives of GSK.

5. This apart, the Reporter has also maliciously exaggerated the Report by referring to the incident with UK advertisement watchdog. However, the Reporter conspicuously concealed the fact that the issue with advertisement in UK was not about the content of the advertisement rather cross-border airing of an advertisement through satellite channel. GSK strongly condemns the insinuation made in the Report and would call upon the authorities of bdnews24.com to exercise discretion before publishing any report on issues.

6. GSK would like to strongly state that it is a responsible entity, driven by science and values. It stands by the quality of its product formulations under various brands marketed by it. GSK follows stringent parameters in the manufacturing and packing process to ensure that all its claims, whether on product packaging and/ or in any communication, are made only after conducting necessary studies and are based on robust scientific research. It is pertinent to note that the Product is also tested at an independent international laboratory and in this case, the presence of the required quantity of DHA is confirmed in the report obtained from the international independent third party laboratory consulted by the Company. Needless to say that such unverified and incorrect Report leads to unnecessary confusion among the public and immensely affects the goodwill of GSK and its business.

7. The Report in question is a mala fide attempt to tarnish the image of GSK and amounts to criminal defamation and GSK holds not just the Reporter but also the Editor and the Publisher of bdnews24.com responsible for the defamation and calls upon the recipients of this rejoinder to tender unconditional apology and retraction of the Report with equal importance.

In view of the above, GSK hereby calls upon the Editor, the Reporter and the Publisher to publish this Rejoinder with equal prominence and seeks retraction of the false report with unconditional apology for publishing misleading and defamatory report immediately on receipt of this Rejoinder, failing which GSK reserves its right to take legal action as it may deem appropriate.

Thanking you and sincerely hoping to see you taking steps to uphold the truth.”

Our response

bdnews24.com stands by its report Junior Horlicks without DHA! The report has no malafide intention and was not done to malign or taint the image of GSK. It was put out purely in public interest after bdnews24.com managed to get the detailed test report from the Bangladesh Council for Scientific and Industrial Research. The rejoinder, published in full, would merely confuse readers instead of clarifying issues raised. bdnews24.com will not apologise and there is no question of retracting the report. The following is our response to some of the points GSK raised:

In the story, bdnews24.com clearly establishes that the product tested was indeed Horlicks Junior which claims to have DHA.

Horlicks advert campaign claims that it makes the consumer ‘taller, stronger and sharper’ were found to be false by the UK Advertising Standards Authority (ASA). The British regulator banned that advertisement for broadcast in the UK for misleading, inaccurate and false claims. The mainstream media in London extensively reported the ASA decision in 2008. bdnews24.com also carried the story at the time.

Also Read:

Junior Horlicks without DHA!
Related Stories